Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
Clinical trial NCT03106610 · TERMINATED
Trial details
- NCT number
- NCT03106610
- Sponsor
- M.D. Anderson Cancer Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-07
- Primary completion
- 2018-05-16
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.